Clinical Trials

210 enrolled

Neoplasm Metastasis, Neoplasms

NCT06298357 2026-03-18

Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation

Phase 1 Completed

11 enrolled

Neoplasms

NCT06658405 2026-03-18

HPV2

Phase 2 Recruiting

85 enrolled

Neoplasms

NCT07202507 2026-03-18

SNOOZE

20 enrolled

Phase 1 Active not recruiting

Neoplasms

NCT04958239 2026-03-17

A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer

151 enrolled

Phase 2/3 Not yet recruiting

Neoplasms

NCT07476443 2026-03-17

VitC-CoQ10

75 enrolled

Neoplasms

NCT00420563 2026-03-16

PAL-ANGI

Phase 2 Completed

88 enrolled

Neoplasms

NCT02439047 2026-03-16

MESO-PATCH

Phase NA Terminated

6 enrolled

Neoplasms

NCT05887882 2026-03-16

PNOC028

24 enrolled

Neoplasms

NCT06072833 2026-03-16

Characterizing and Addressing Financial Toxicity in AYAs With Cancer

26 enrolled 8 charts

Neoplasms

NCT06150157 2026-03-16

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

220 enrolled

Neoplasms

NCT06997029 2026-03-16

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

234 enrolled

Neoplasms

NCT07030712 2026-03-16

MK-8294-001

67 enrolled

Phase 1 Active not recruiting

Neoplasm Metastasis, Neoplasms

NCT07474168 2026-03-16

T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor

9 enrolled

Neoplasms

NCT00580515 2026-03-13

Trial of Family Focused Grief Therapy in Palliative Care and Bereavement

700 enrolled

Neoplasms

NCT05862285 2026-03-13

UmbrellaMAX

Phase 3 Recruiting

100 enrolled

Neoplasms

NCT05909202 2026-03-13

A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients

218 enrolled

Neoplasms

NCT06178614 2026-03-13

A Study of JNJ-87890387 for Advanced Solid Tumors

200 enrolled

Neoplasms

NCT06941272 2026-03-13

MK-9999-01C

Phase 1/2 Recruiting

50 enrolled

Phase 1 Not yet recruiting

Neoplasms

NCT07454031 2026-03-13

Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

22 enrolled

Phase 1/2 Active not recruiting

Neoplasm Metastasis, Neoplasms

NCT02908906 2026-03-12

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers

413 enrolled

Neoplasms

NCT04803604 2026-03-12

CASCADE

256 enrolled

Neoplasms

NCT06445140 2026-03-12

MONAGE

55 enrolled

Neoplasms

NCT06959810 2026-03-12

OEUVRE

55 enrolled

Neoplasms

NCT05763797 2026-03-11

Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer

170 enrolled

Phase 2 Active not recruiting

Neoplasms

NCT05993299 2026-03-11

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

7 enrolled 15 charts

Neoplasms

NCT06864260 2026-03-11

PREEMpT

300 enrolled

Neoplasms

NCT06901531 2026-03-11

LUCERNA

Phase 3 Recruiting

500 enrolled

Phase NA Not yet recruiting

Adenocarcinoma, Neoplasms

NCT07463547 2026-03-11

WISE

20 enrolled

Neoplasms

NCT04333706 2026-03-10

EMPOWER

Phase 1/2 Recruiting

65 enrolled

Neoplasm Metastasis, Neoplasms

NCT03366116 2026-03-09

5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

65 enrolled

Neoplasms

NCT04449549 2026-03-09

Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel

Phase 2 Recruiting

82 enrolled

Neoplasms

NCT04723810 2026-03-09

TumorGlow Intraoperative Molecular Imaging (IMI)

Phase 1/2 Recruiting

500 enrolled

Phase 1 Active not recruiting

Neoplasms

NCT05707910 2026-03-09

Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors

6 enrolled

Neoplasms

NCT06549153 2026-03-09

ACT-Together (Acting on Cancer Testing-Together)

30 enrolled

Neoplasms

NCT07454330 2026-03-09

Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors

64 enrolled

Neoplasms

NCT01428895 2026-03-06

Femoral Bone Metastases

180 enrolled

Neoplasms

NCT02423057 2026-03-06

Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors

Phase 1 Completed

27 enrolled

Neoplasms

NCT02840058 2026-03-06

ITHER

295 enrolled

Neoplasms

NCT05831579 2026-03-06

Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy

24 enrolled

Neoplasm Metastasis, Neoplasms

NCT05886764 2026-03-06

Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials

180 enrolled

Neoplasms

NCT06048822 2026-03-06

Enhancing Cancer Survivorship With Pickleball

28 enrolled

Neoplasms

NCT06248450 2026-03-06

YouCanPrefer

163 enrolled

Neoplasms

NCT06340815 2026-03-06

Varian ProBeam Proton Therapy System Clinical Trial (Shandong)

47 enrolled

Neoplasms

NCT06555744 2026-03-06

A Study of ZW191 in Participants With Solid Tumors

145 enrolled

Neoplasms

NCT06564233 2026-03-06

Supportive Care Intervention for Outpatient Stem Cell Transplant Patients

90 enrolled

Neoplasms

NCT06905002 2026-03-06

Enhancing the Patient Journey to Clinical Trial Enrolment With Navigation to Optimize Accrual

300 enrolled

Neoplasms

NCT06979596 2026-03-06

OMAHA-015

Phase 2 Recruiting

250 enrolled

Phase NA Not yet recruiting

Neoplasms

NCT07454499 2026-03-06

Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

60 enrolled